- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02882802
Mindfulness for Anger in Veterans With PTSD
Mindfulness Treatment for Anger in Veterans With PTSD
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Military Veterans suffering from posttraumatic stress disorder (PTSD) have been shown to exhibit increases in aggressive urges, difficulties managing anger, and difficulties controlling violent behavior. Dysregulated anger and aggression can create fear and distress in spouses, family members, and friends resulting in strained and deteriorated relationships, and can have a detrimental impact on Veterans' social, occupational and other important areas of functioning. In addition, more severe forms of aggression and violent behavior (i.e., homicide) in the community have been observed among Veterans with PTSD, as recently reported in several news media outlets. The seriousness of this problem is underscored by the high rates of alcohol use observed among Veterans with PTSD which further increases anger and the risk of aggressive behavior.
Current therapeutic interventions may not be effective in reducing anger and aggressive behavior among Veterans with PTSD due to the lack of techniques that directly target symptoms most strongly associated with aggression, particularly hyperarousal and physiological reactivity. Furthermore, existing interventions may not be effective in assisting individuals achieve awareness and insight into their anger states, necessary for the effective management of anger and aggression. Mindfulness is rooted in Eastern meditation practices and has been successfully used to decrease stress, pain, anxiety, and depression. In civilian samples, mindfulness interventions have been found to be effective in reducing anger and aggression. To date, mindfulness for anger and aggression has not been examined in Veterans with PTSD.
The primary objective of the proposed investigation is to conduct a pilot randomized control trial to examine the initial efficacy of an established mindfulness intervention, Mindfulness Based Stress Reduction (MBSR) in decreasing anger and aggression in Veterans with PTSD. The proposed investigation also seeks to examine potential mechanisms of action that account for its effects. Sixty Veterans with PTSD experiencing problems with anger and aggression will be recruited. These individuals will complete a baseline assessment to assess self-reported levels of anger and aggression. They will then be randomly assigned to participate in an online (i.e., virtual) PTSD psychoeducational course or MBSR. After completing treatment, all participants will complete a post-treatment assessment to assess changes in anger and aggression.
At a later date and time, participants will also be asked to attend an in-person laboratory session where they will engage in a trauma-imagery procedure followed by a task designed to assess provoked aggression. In addition to examining whether participation in MBSR decreases self-reported levels of anger and aggression, this study will examine whether MBSR decreases aggression in participants after being exposed to trauma reminders in vivo. Potential mechanisms of action of MBSR and its effects on additional outcomes also will be explored.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
West Haven, Connecticut, United States, 06516-2770
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must meet current Diagnostic and Statistical Manual of Mental Disorders (5th edition) diagnostic criteria for PTSD (participants with sub-threshold levels of PTSD will also be allowed to participate).
- Participants must also indicate current difficulties with anger and aggression.
Exclusion Criteria:
- Participants with a current diagnosis of psychotic disorder or current substance use disorder with severe symptoms.
- Participants diagnosed with bipolar II disorder without psychotic features and/or individuals diagnosed with bipolar disorder who are well-controlled on medication will be allowed to participate. Individuals with bipolar disorder who do not fall into either of these categories will be excluded.
- Participants also must not have a seizure disorder.
- Participants are allowed to be taking psychotropic medications, however they must be on a stable dose for at least 2 months.
- Participants who do not have a working and active e-mail account and access to a smart phone or computer will be excluded.
- Finally, participants must not currently be receiving concurrent individual therapy or group therapy focused on anger and aggression, must not be currently receiving any evidence-based treatment for PTSD, and must not currently be participating in the modified TREC group offered at the West Haven VA Medical Center.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness Based Stress Reduction
Mindfulness Based Stress Reduction (MBSR) is a group-based intervention in which participants are taught different mindfulness meditation practices, including body scan (focusing attention to different areas of the body in sequence), sitting meditation (focusing attention to one's breathing), and Hatha yoga postures (focusing attention to different body sensations during gentle stretching).
Participants also are taught how to practice mindfulness while engaging in ordinary activities including walking, standing, and eating.
MBSR consists of 8, two-hour weekly sessions and will be delivered in group format.
MBSR groups will be delivered virtually.
|
Mindfulness Based Stress Reduction (MBSR) is a group-based intervention in which participants are taught different mindfulness meditation practices, including body scan (focusing attention to different areas of the body in sequence), sitting meditation (focusing attention to one's breathing), and Hatha yoga postures (focusing attention to different body sensations during gentle stretching).
Participants also are taught how to practice mindfulness while engaging in ordinary activities including walking, standing, and eating.
MBSR consists of 8, two-hour weekly sessions and will be delivered in group format.
MBSR groups will be delivered virtually.
Other Names:
|
|
Active Comparator: Trauma Recovery Education Class
Trauma Recovery Education Class (TREC): TREC is a group based treatment that focuses on providing information on PTSD and traumatic reactions.
TREC provides psycho-education to Veterans on PTSD, including common reactions to trauma and the role of avoidance, common problems associated with PTSD, as well as common barriers to care (e.g., stigma, maladaptive beliefs, fear).
Additional content focuses on problem identification and goal setting, discussion of current problems and life issues, and treatment planning.
TREC consists of 8, one-hour weekly sessions.
TREC groups will be delivered virtually.
|
Trauma Recovery Education Class (TREC): TREC is a group based treatment that focuses on providing information on PTSD and traumatic reactions.
TREC provides psycho-education to Veterans on PTSD, including common reactions to trauma and the role of avoidance, common problems associated with PTSD, as well as common barriers to care (e.g., stigma, maladaptive beliefs, fear).
Additional content focuses on problem identification and goal setting, discussion of current problems and life issues, and treatment planning.
TREC consists of 8, one-hour weekly sessions.
TREC groups will be delivered virtually.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State Anger Scale
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Self-report measure of overall state anger using the State-Trait Anger Expression Inventory-2.
Score range: 15-60; higher scores indicate greater state anger.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Trait Anger Scale
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Self-report measure of trait anger using the State-Trait Anger Expression Inventory-2.
Score range: 10-40; higher scores indicate greater trait anger.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Anger Expression In
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Self-report measure of anger expression inward using the State-Trait Anger Expression Inventory-2.
Score range: 8-32; higher scores indicate greater frequency of experiencing anger but not expressing (i.e., suppressing) anger.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Anger Expression Out
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Self-report measure of anger expression outward using the State-Trait Anger Expression Inventory-2.
Score range: 8-32; higher scores indicate greater frequency of expressing anger verbally or physically.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Anger Control In
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Self-report measure of anger control inward using the State-Trait Anger Expression Inventory-2.
Score range: 8-32; higher scores indicate greater frequency of attempting to control anger feelings by calming down or cooling off.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Anger Control Out
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Self-report measure of anger control outward using the State-Trait Anger Expression Inventory.
Score range: 8-32; higher scores indicate greater frequency of controlling outward expression of angry feelings.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Anger Expression Index
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Total Anger score on the STAXI-2.
Score range: 0-96; higher scores indicate greater expression of anger.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Buss Perry Total Aggression Score
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
Self-report measure of total aggression using the Buss-Perry Aggression Questionnaire.
Scores range from 29-203; greater scores indicate greater total aggression.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Buss Perry Physical Aggression
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
self-report measure assessing physical aggression using Buss Perry Aggression Questionnaire.
Scores range from 9-63; greater scores indicate greater total physical aggression.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Buss Perry Verbal Aggression Score
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
self-report measure assessing verbal aggression using Buss Perry Aggression Questionnaire.
Scores range from 5-35; greater scores indicate greater total verbal aggression.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Buss Perry Anger Scale
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
self-report measure of anger using the Buss Perry Aggression Questionnaire.
Scores range from 7-49; greater scores indicate greater total anger.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Buss Perry Hostility Scale
Time Frame: Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
self-report measure of hostility using the Buss Perry Aggression Questionnaire.
Scores range from 8-56; greater scores indicate greater total hostility.
|
Baseline, after 3 weeks of treatment, after 6 weeks of treatment, within 8 weeks following the completion of either of the two treatments (i.e., post-treatment), and within 5 months after completing the post-treatment assessment
|
|
Provoked Aggression Subscale 1
Time Frame: within 8 weeks following the completion of either of the two treatments
|
An experimental lab-based paradigm designed to assess provoked aggression, the Taylor Reaction Time Task.
This subscale determines whether participants' aggression increased, decreased, or remained the same across four blocks of trials (six trials within each block).
Scores range from 0-11 within each trial, with higher scores indicating worse outcome.
Each of the six trials within each block are averaged together.
|
within 8 weeks following the completion of either of the two treatments
|
|
Provoked Aggression Subscale 2
Time Frame: within 8 weeks following the completion of either of the two treatments
|
An experimental lab-based paradigm designed to assess provoked aggression, the Taylor Reaction Time Task.
This subscale determines participants' initial levels of aggression.
Participants can choose from the following response options: 0, 1, 2, 3, 4, 5, 6, 7,8, 9, 10 or 20, with higher scores indicating greater initial levels of aggression.
|
within 8 weeks following the completion of either of the two treatments
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
heart rate
Time Frame: within 4 weeks following the completion of either of the two treatments
|
physiological assessment implemented while participants are exposed to trauma narratives
|
within 4 weeks following the completion of either of the two treatments
|
|
skin-conductance levels
Time Frame: within 4 weeks following the completion of either of the two treatments
|
physiological assessment implemented while participants are exposed to trauma narratives
|
within 4 weeks following the completion of either of the two treatments
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin Conductance Levels
Time Frame: within 8 weeks following the completion of either of the two treatments
|
Changes in skin conductance levels during the trauma narrative portion of the lab session.
|
within 8 weeks following the completion of either of the two treatments
|
|
Heart Rate
Time Frame: within 8 weeks following the completion of either of the two treatments
|
Changes in heart rate during the trauma narrative portion of the lab session.
|
within 8 weeks following the completion of either of the two treatments
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lorig Kachadourian, PhD MA, VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLNA-006-15F
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anger
-
Ege UniversityCompleted
-
naomi goldsteinNational Institute of Mental Health (NIMH)Completed
-
Walter Reed Army Institute of Research (WRAIR)Enrolling by invitation
-
Florida State UniversityCompletedAnger | Smoking CessationUnited States
-
Örebro University, SwedenKarolinska InstitutetCompletedMaladaptive Anger InhibitionSweden
-
Karolinska InstitutetCompletedInappropriate Anger ExpressionSweden
-
Kafkas UniversityCompleted
-
Mersin UniversityCompletedAnger Problems | Spiritual Well-beingTurkey (Türkiye)
-
Aydin Adnan Menderes UniversityCompletedAnger | Nurse's Role | Interpersonal RelationsTurkey
-
University of Colorado, DenverChildrens Hospital ColoradoRecruitingAnger | Irritable Mood | Temper TantrumUnited States
Clinical Trials on Mindfulness Based Stress Reduction
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Inflammation | Stress, Psychological | SleepUnited States
-
University of California, San FranciscoCompletedDementia | Frontotemporal Dementia | Frontotemporal Lobar Degeneration | Caregiver Stress Syndrome | Caregiver Burnout | Dementia Frontal | Mindfulness Based Stress ReductionUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingChronic Low-back PainUnited States
-
Oregon Health and Science UniversityPortland VA Medical CenterCompleted
-
Fatima Jinnah Women UniversityRecruitingBehavior Problem | Emotional ProblemPakistan
-
Fatima Jinnah Women UniversityNot yet recruitingPsychological StressPakistan
-
University of PaviaUniversity of Siena, ItalyCompletedWell-being | Work-Related Stress | Employees of University | Inflammation StatusItaly
-
Toronto Metropolitan UniversityCompleted
-
Saglik Bilimleri UniversitesiCompletedObesity | Polycystic Ovary Syndrome | StressTurkey
-
Medicos e Investigadores en la Lucha contra el...CompletedBreast Cancer | Anxiety | SurvivorshipMexico